# Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

> **NCT04895059** · PHASE1 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rosuvastatin (20mg) /Ezetimibe (10mg) in fixed dose
- **DRUG:** Rosuvastatin 20mg
- **DRUG:** Ezetimibe 10mg

## Key facts

- **NCT ID:** NCT04895059
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-30
- **Primary completion:** 2018-01-15
- **Final completion:** 2018-01-22
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04895059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04895059, "Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04895059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*